Table 1 Utilities considered in the model
Therapeutic path | Utility | Months | Source |
|---|---|---|---|
r-FSH + r-LH (MIN - MAX) | 0.8 (0.72–0.88) | 1 | Expert opinion |
HP-hMG (MIN - MAX) | 0.8 (0.72–0.88) | 1 | Expert opinion |
Positive hCGtest (MIN - MAX) | 0.9 (0.81–0.99) | 3 | Expert opinion |
Negative hCGtest (MIN - MAX) | 0.7 (0.63–0.77) | 5 | Expert opinion |
Clinical pregnancy (MIN - MAX) | 1 (0.90–1.00) | 2 | Expert opinion |
Miscarriage (MIN - MAX) | 0.5 (0.45–0.55) | 2 | Expert opinion |
Cycle with embryo freezing (MIN - MAX) | 0.9 (0.81–0.99) | 1 | Expert opinion |
Cycle without embryo freezing (MIN - MAX) | 0.8 (0.72–0.88) | 1 | Expert opinion |
Dropout (MIN - MAX) | 0.4 (0.36–0.44) | 6 | Expert opinion |